Browsing by Author Baran, Yusuf

Showing results 74 to 93 of 173 < previous   next >
Issue DateTitleAuthor(s)
2013Gossypol interferes with both type I and Type II topoisomerase activities without generating strand breaksŞenarısoy, Müge; Cantürk, Pakize; Zencir, Sevil; Baran, Yusuf ; Topçu, Zeki
2013Granulocytic sarcoma: a systematic reviewYılmaz, Asu Fergün; Saydam, Güray; Şahin, Fahri; Baran, Yusuf 
2023HER2-specific peptide (LTVSPWY) and antibody (herceptin) targeted core cross-linked micelles for breast cancer: A Comparative studyBayram, N.N.; Ulu, G.T.; Abdulhadi, N.A.; Gürdap, S.; İşoğlu, İ.A.; Baran, Yusuf ; İşoğlu, S.D.
28-Oct-2021HER2-targeted, degradable core cross-linked micelles for specific and dual pH-sensitive DOX releaseBayram, Nazende Nur; Ulu, Gizem Tuğçe ; Topuzoğulları, Murat; Baran, Yusuf ; Dinçer İşoğlu, Sevil
2022HER2-Targeted, Degradable Core Cross-Linked Micelles for Specific and Dual pH-Sensitive DOX ReleaseBayram, N.N.; Ulu, G.T.; Topuzoğulları, M.; Baran, Y. ; Dinçer, İşoğlu, S.
2018Hesperidin promotes programmed cell death by downregulation of nongenomic estrogen receptor signalling pathway in endometrial cancer cellsCincin, Zeynep Birsu; Kıran, Bayram; Baran, Yusuf ; Çakmakoğlu, Bedia
2011Hormona dirençli prostat kanseri hücrelerinde dosetaksel ve seramidin induklediği apoptozisde seramid genlerinin ve ürünlerinin eksprersyon düzeylerinin araştırılmasıBaran, Yusuf 
Mar-2011Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cellsCan, Geylani; Ekiz, Hüseyin Atakan ; Baran, Yusuf 
2009Imatinib induces autophagy through increasing the expression levels of Beclin-1 and ATG-5 genes in both parental sensitive and imatinib-resistant K562 cellsBaran, Yusuf ; Can, Geylani; Ekiz, Hüseyin Atakan ; Genç, S. G.
6-Dec-2011Imatinib-induced apoptosis: A possible link to topoisomerase enzyme inhibitionBaran, Yusuf ; Zencir, Sevil; Çakır, Zeynep; Öztürk, Esra; Topçu, Zeki
2013Immunologically detection of BCR/ABL fusion protein with flow cytometry in K562 chronic myeloid leukemia cells and comparison with RT-PCR resultsKozanoğlu, İlknur; Aygün, B.; Boğa, I.; Cansun, C.; Üstündağ, N.; Baran, Yusuf ; Özdoğu, Hakan
2011The importance of protein profiling in the diagnosis and treatment of hematologic malignanciesŞanlı Mohamed, Gülşah ; Turan, Taylan; Ekiz, Hüseyin Atakan ; Baran, Yusuf 
2010Increasing chemosensitivity of chronic myeloid leukemia cells to dasatinib by targeting bioactive sphingolipidsGencer, Emel Başak
2009Increasing de novo synthesis of ceramides increased nilotinib induced apoptosis in human MEG-01 chronic megacaryoblastic cellsBaran, Yusuf ; Gençer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit
2009Increasing intracellular generation or accumulation of ceramides increased cytotoxic effects of resveratrol in human k562 chronic myeloid leukemia cellsKartal Yandım, Melis; Saydam, Güray; Şahin, Fahri; Baran, Yusuf 
2014Inhibition of jumonji C domain containing histone demethylases in acute myeloid leukemiaHastar, N.; Koca, D.; Baran, Yusuf 
Jan-2017Intraperitoneal mesenchymal stem cell administration ameliorates allergic rhinitis in the murine modelIşık, Sakine; Karaman, Meral; Adan, Aysun ; Kıray, Müge; Bağrıyanık, Hüsnü Alper; Çağlayan Sözmen, Şule; Kozanoğlu, İlknur; Karaman, Özkan; Baran, Yusuf ; Uzuner, Nevin
Jul-2022Investigating the potential therapeutic role of targeting STAT3 for overcoming drug resistance by regulating energy metabolism in chronic myeloid leukemia cellsTezcanlı Kaymaz, Burçin; Günel, Nur Selvi; Söğütlü, Fatma; Özateş Ay, Neslihan Pınar; Baran, Yusuf ; Gündüz, Cumhur; Biray Avcı, Çığır
2014Investigation of effects of fisetin, vitexin and hesperetin on chronic myeloid leukemia cellsAdan Gökbulut, Aysun ; Baran, Yusuf 
2019Investigation of potential anticarcinogenic effects of corilagin in lung cancer cellsRencüzoğulları, Çağla; Çinçin, Zeynep Birsu; İplik, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia